Clinical Update

Parvovirus B19: An opportunistic healthcare burden

Authors

  • N Goolam Internal Medicine Department, Eerste River Hospital, Cape Town, South Africa

DOI:

https://doi.org/10.7196/SAMJ.2022.v112i11.16663

Keywords:

Parvovirus B19

Abstract

Parvovirus B19 is notoriously a cause of normocytic anaemia in patients in an immunocompromised state, more so than in patients without prior disease. It is increasingly prevalent in children and adults in an HIV-induced immunocompromised state, and its presentation may be varied. Red-cell aplasia and normocytic anaemia are common presenting derangements found. Here, we note the typical presentation of red-cell aplasia re-entering healthcare, with a dire effect on the quality of life of this patient.

References

Sim JY, Chang LY, Chen JM, et al. Human parvovirus B19 infection in patients with or without underlying diseases. J Microbiol Immunol Infect 2019;52(4):534-541. https://doi.org/10.1016/j. jmii.2019.05.009

Woolf AD, Campion GV, Chishick A, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989;149(5):1153-1156.

Nasir IA, Medugu T, Dangana A. Human parvovirus B19-associated hematopathy in HIV disease: Need for clinicopathological revisit. J Biomed Res 2018;32(1):1-2. https://doi.org/10.7555/JBR.32.2017010 4. Clarke J, Lee JD. Primary human parvovirus B19 infection in an HIV-infected patient on highly active

antiretroviral therapy. Sex Transm Infect 2003;79(4):336. https://doi.org/10.1136/sti.79.4.336

Wilson D. Haematology. In: Maartens G, Cotton M, Wilson D, Venter F, Meyers T, Bekker L (editors). Oxford Handbook of HIV Medicine. Third ed. Johannesburg: Oxford University Press Southern

Africa, 2012:305-306.

LouwS.ParvovirusB19...anopportunist.https://sahivsoc.org/Files/13C%20-%20Susan%20Louw%20

-%20Parvo%20virus%20(PB19).pdf (accessed 17 October 2022).

Southern African HIV Clinicians Society. Guideline for the prevention, diagnosis and management of

cryptococcal disease among HIV-infected persons: 2019 update. sajhivmed. https://sahivsoc.org/Files/

crypto%20guidelines.pdf (accessed 10 January 2022).

Volberding PA, Levine AM, Dieterich D, et al. Anemia in HIV Working Group. Anemia in

HIV infection: Clinical impact and evidence-based management strategies. Clin Infect Dis

;38(10):1454-1463. https://doi.org/10.1086/383031

Durandt C, Potgieter JC, Mellet J, et al. HIV and haematopoiesis. S Afr Med J 2019;109( 8b):40-45.

https://doi.org/10.7196/SAMJ.2019.v109i8b.13829

Subbaraman R, Devaleenal B, Selvamuthu P, et al. Factors associated with anaemia in HIV-infected individuals in southern India. Int J STD AIDS 2009;20(7):489-492. https://doi.org/10.1258/ ijsa.2008.008370

Downloads

Published

2022-11-01

Issue

Section

In Practice

How to Cite

1.
Goolam N. Clinical Update: Parvovirus B19: An opportunistic healthcare burden. S Afr Med J [Internet]. 2022 Nov. 1 [cited 2024 Dec. 1];112(11):840-1. Available from: https://samajournals.co.za/index.php/samj/article/view/399